Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells

被引:55
作者
Wulhfard, Sarah [1 ]
Baldi, Lucia [1 ]
Hacker, David L. [1 ]
Wurm, Florian [1 ,2 ]
机构
[1] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Cellular Biotechnol, CH-1015 Lausanne, Switzerland
[2] ExcellGene SA, CH-1870 Monthey, Switzerland
关键词
Valproic acid; Histone deacetylase inhibitor; Transient gene expression; Transgene mRNA; CHO cells; Orbital shaking; Polyethylenimine; LOW CULTURE TEMPERATURE; GENE-EXPRESSION; MAMMALIAN-CELLS; TRANSCRIPTION LEVEL; PRODUCTIVITY; INHIBITORS; BUTYRATE; GROWTH; CANCER; DNA;
D O I
10.1016/j.jbiotec.2010.05.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Valproic acid (VPA) is a small molecule that inhibits histone deacetylase activity. Here we report that VPA increases recombinant mRNA and protein levels in transiently transfected CHO DG44 cells. In the presence of VPA, transient recombinant antibody yields of up to 40 mg/L were achieved in simple batch cultures. The steady-state levels of the IgG light and heavy chain mRNAs were nearly 10 times higher than in the untreated control transfection even though the level of transfected plasmid DNA was the same in the presence or absence of VPA. The combination of VPA treatment and incubation of the transfected cells in mildly hypothermic conditions resulted in recombinant antibody yields of over 90 mg/L by 6 days post-transfection in batch cultures. The results demonstrated that the treatment of transfected CHO DG44 cells with VPA is a cost-effective strategy for enhancing transient gene expression by increasing the transgene mRNA levels. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 33 条
[1]   Identification of novel small molecule enhancers of protein production by cultured mammalian cells [J].
Allen, Martin J. ;
Boyce, James P. ;
Trentalange, Michael T. ;
Treiber, David L. ;
Rasmussen, Brian ;
Tillotson, Benjamin ;
Davis, Raymond ;
Reddy, Pranhitha .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 100 (06) :1193-1204
[2]   Valproic acid: A viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures [J].
Backliwal, Gaurav ;
Hildinger, Markus ;
Kuettel, Ivan ;
Delegrange, Fanny ;
Hacker, David L. ;
Wurm, Florian M. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 101 (01) :182-189
[3]   Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions [J].
Backliwal, Gaurav ;
Hildinger, Markus ;
Chenuet, Sebastien ;
Wulhfard, Sarah ;
De Jesus, Maria ;
Wurm, Florian M. .
NUCLEIC ACIDS RESEARCH, 2008, 36 (15)
[4]   Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives [J].
Baldi, Lucia ;
Hacker, David L. ;
Adam, Myriam ;
Wurm, Florian M. .
BIOTECHNOLOGY LETTERS, 2007, 29 (05) :677-684
[5]   PHARMACOKINETICS OF VALPROMIDE AFTER ORAL-ADMINISTRATION OF A SOLUTION AND A TABLET TO HEALTHY-VOLUNTEERS [J].
BIALER, M ;
RUBINSTEIN, A ;
RAZ, I ;
ABRAMSKY, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (04) :501-503
[6]   Regulation of ER stress proteins by valproate: therapeutic implications [J].
Bown, CD ;
Wang, JF ;
Chen, B ;
Young, LT .
BIPOLAR DISORDERS, 2002, 4 (02) :145-151
[7]   Activation of CMV promoter-controlled glycosyltransferase and β-galactosidase glycogenes by butyrate, tricostatin A, and 5-Aza-2′-deoxycytidine [J].
Choi, KH ;
Basma, H ;
Singh, J ;
Cheng, PW .
GLYCOCONJUGATE JOURNAL, 2005, 22 (1-2) :63-69
[8]   Sodium valproate inhibits in vivo growth of human neuroblastoma cells [J].
Cinatl, J ;
Cinatl, J ;
Driever, PH ;
Kotchetkov, R ;
Pouckova, P ;
Kornhuber, B ;
Schwabe, D .
ANTI-CANCER DRUGS, 1997, 8 (10) :958-963
[9]   Inhibition of histone deacetylase activity by butyrate [J].
Davie, JR .
JOURNAL OF NUTRITION, 2003, 133 (07) :2485S-2493S
[10]   Serum-free large-scale transient transfection of CHO cells [J].
Derouazi, M ;
Girard, P ;
Van Tilborgh, F ;
Iglesias, K ;
Muller, N ;
Bertschinger, M ;
Wurm, FM .
BIOTECHNOLOGY AND BIOENGINEERING, 2004, 87 (04) :537-545